SEC Form 4 · accession 0001914879-26-000004
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Lynne Fox
Officer — Chief Legal Officer
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 3, 2026 | F | 4,398 | $3.23 | D | 305,964 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026.